Fortress Biotech, Inc. (FBIO)
3.315
-0.10
(-3.07%)
USD |
NASDAQ |
Mar 02, 16:00
3.315
0.00 (0.00%)
After-Hours: 17:40
Fortress Biotech EPS Diluted (Quarterly) : 0.111 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Oramed Pharmaceuticals, Inc. | 1.131 |
| Avenue Therapeutics, Inc. | -0.2145 |
| Lyell Immunopharma, Inc. | -2.126 |
| Climb Bio, Inc. | -0.1895 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 8.827M |
| Revenue (Quarterly) | 17.63M |
| Total Expenses (Quarterly) | 11.78M |
| Enterprise Value | 97.55M |
| Gross Profit Margin (Quarterly) | 60.80% |
| Profit Margin (Quarterly) | 50.07% |
| Earnings Yield | -8.08% |
| Normalized Earnings Yield | -10.40 |